Page last updated: 2024-10-26

dipyridamole and Cancer of Rectum

dipyridamole has been researched along with Cancer of Rectum in 3 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"In HCT 116 cells, a human colon cancer cell line, the levels of thymidine (0."1.27Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. ( Fischer, PH; Pangallo, CA; Van Mouwerik, TJ; Willson, JK, 1987)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dollinger, MR1
Krakoff, IH1
Van Mouwerik, TJ1
Pangallo, CA1
Willson, JK1
Fischer, PH1
Wadler, S1
Subar, M1
Green, MD1
Wiernik, PH1
Muggia, FM1

Other Studies

3 other studies available for dipyridamole and Cancer of Rectum

ArticleYear
Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue.
    Clinical pharmacology and therapeutics, 1975, Volume: 17, Issue:1

    Topics: Adenosine; Adult; Bilirubin; Blood Cell Count; Breast Neoplasms; Dipyridamole; Erythrocytes; Female;

1975
Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
    Biochemical pharmacology, 1987, Mar-15, Volume: 36, Issue:6

    Topics: Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Synergism; Guanine; Humans; Hypoxant

1987
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
    Cancer treatment reports, 1987, Volume: 71, Issue:9

    Topics: Adenocarcinoma; Administration, Oral; Aged; Colonic Neoplasms; Dipyridamole; Drug Evaluation; Drug T

1987